Literature DB >> 17323225

Olanzapine orally-disintegrating tablet in severe psychotic agitation: a naturalistic study.

J C Pascual1, V Pérez, J L R Martín, G Safont, D Puigdemont, E Alvarez.   

Abstract

INTRODUCTION: This study was conducted to determine effectiveness and safety of olanzapine in patients with severe agitation.
METHOD: A naturalistic, open-label study in 80 acutely agitated psychotic patients visited in our psychiatric emergency department. Patients received either a 20-mg olanzapine orally-disintegrating tablet or conventional treatment depending on attending psychiatrist's preference. Efficacy was assessed by the Excitement Component of the Positive and Negative Syndrome Scale (PANSS-EC), the Agitation-Calmness Evaluation Scale (ACES) and pragmatic variables (second pharmacological intervention and need for physical restraints).
RESULTS: 60 % patients completed a 6 hour trial. Both groups showed a significant reduction in mean PANSS-EC score. The olanzapine-treated group showed statistically significant improvements: PANSS-EC (F=122.9; df=2.4; p=0.000), ACES (F=68.2; df=2.8; p=0.000). Treatment was well-tolerated and no serious side-effects were observed.
CONCLUSIONS: In this naturalistic study in patients with severe agitation, 20-mg oral olanzapine was effective, rapid and safe.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323225

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  4 in total

Review 1.  Management of Violence and Aggression in Emergency Environment; a Narrative Review of 200 Related Articles.

Authors:  Maryam Ziaei; Ali Massoudifar; Ali Rajabpour-Sanati; Ali-Mohammad Pourbagher-Shahri; Ali Abdolrazaghnejad
Journal:  Adv J Emerg Med       Date:  2018-11-29

2.  Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.

Authors:  Istvan Bitter; Tamás Treuer; Nesrin Dilbaz; Igor Oyffe; Eda M Ciorabai; Severiano L Gonzalez; Sandra Ruschel; Jolanta Salburg; Yulia Dyachkova
Journal:  World J Biol Psychiatry       Date:  2010-10       Impact factor: 4.132

3.  Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties.

Authors:  William Montgomery; Tamas Treuer; Jamie Karagianis; Haya Ascher-Svanum; Gavan Harrison
Journal:  Patient Prefer Adherence       Date:  2012-02-01       Impact factor: 2.711

4.  Effectiveness and medication acceptance of olanzapine disintegrating tablets compared to standard olanzapine tablets in acutely treated psychiatric patients.

Authors:  Jörg Czekalla; Thomas Wagner; Alexander Schacht; Michael Kluge; Bruce Kinon
Journal:  Patient Prefer Adherence       Date:  2007-12-20       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.